Summit Therapeutics (NASDAQ:SMMT) is set to give its latest quarterly earnings report on Wednesday, 2024-10-30. Here's what investors need to know before the announcement.
Analysts estimate that Summit Therapeutics will report an earnings per share (EPS) of $-0.07.
Summit Therapeutics bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Earnings Track Record
The company's EPS beat by $0.01 in the last quarter, leading to a 1.47% drop in the share price on the following day.
Here's a look at Summit Therapeutics's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.06 | |||
| EPS Actual | -0.05 | -0.06 | -0.05 | -0.03 |
| Price Change % | -1.0% | -14.000000000000002% | 10.0% | -5.0% |
To track all earnings releases for Summit Therapeutics visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
